1276666-14-8

Basic information

• Product Name: (R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate
• Synonyms: (R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate;(5R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-5-methyl-1,4-diazepan-1-ium (2S,3S)-2,3-bis(benzoyloxy)butanedioate;(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-ium (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate;Butanedioic acid, 2,3-bis(benzoyloxy)-, (2S,3S)-, compd. with 5-chloro-2-[(5R)-hexahydro-5-methyl-1H-1,4-diazepin-1-yl]benzoxazole (1:1);(R)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole (2S,3S)-2,3-bis(benzoyloxy)succinate
• CAS NO: 1276666-14-8
• Molecular Formula: C₁₃H₁₆ClN₃O*C₁₈H₁₄O₈
• Molecular Weight: 624.0376
• Mol File: 1276666-14-8.mol
• Article Data: 2

Chemical Properties

• Melting Point: 164.2℃
• Appearance: /
• CAS DataBase Reference: (R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate(1276666-14-8)
• EPA Substance Registry System: (R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate(1276666-14-8)

Safety Data

• Hazardous Substances Data: 1276666-14-8(Hazardous Substances Data)

Usage

General Description

The chemicals "(R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM" and "(2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate" are complex organic compounds that contain multiple functional groups. The former compound includes a chlorobenzo[d]oxazole moiety and a 7-methyl-1,4-diazepane moiety, suggesting potential bioactive properties, though specific applications or bioactivities are not mentioned. The latter compound contains bis(benzoyloxy) and carboxypropanoate groups, indicating potential use in organic reactions. Without specific information on their use or context, it is difficult to provide a more detailed summary, but these compounds, like many complex organic molecules, may be synthesized for use in pharmaceuticals, material science, or chemical research.

Upstream product

• 95-85-2 2-hydroxy-5-chloro-aniline 
• 1276666-10-4 {2-[(5-chlorobenzoxazol-2-yl)-(3-oxo-butyl)amino]ethyl}carbamic acid tert-butyl ester 
• 17026-42-5 O,O'-dibenzoyl-D-tartaric acid 
• 1276666-13-7 5-chloro-2-(5-methyl-[1,4]diazepan-1-yl)-benzoxazole 
• 3621-81-6 2,5-dichloro-1,3-benzoxazole 
• 22876-19-3 5-chloro-2-mercaptobenzoxazole 
• 1144509-75-0 (2-((5-chloro-1,3-benzoxazol-2-yl)amino)ethyl)carbamic acid tert-butyl ester 

Downstream Products

• 1030377-33-3 Suvorexant 

Relevant articles and documents

PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST

The present invention is directed to processes for preparing a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is further directed to crystalline forms of this diazepane compound and pharmaceutical compositions thereof.